Search results
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks via Yahoo Finance· 2 days agoThe Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE)...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
KFGO· 1 day agoBy Michael Erman (Reuters) - Novavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators accept the shot it has started manufacturing ...
Oracle, Moderna, Palantir Technologies And A Big Bank On CNBC’s ‘Final Trades’ - Oracle (NYSE:ORCL)
Benzinga· 4 days agoOn CNBC's "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners named Oracle Corporation...
Free COVID-19 vaccines could be a thing of the past. Experts weigh in.
USA TODAY via Yahoo News· 4 days agoModerna did not respond to a request for comment. When a federal panel broadly recommended the...
Researchers develop mRNA vaccine for strain of avian flu | Arkansas Democrat Gazette
Arkansas Democrat-Gazette· 18 hours agoUniversity of Pennsylvania researchers have developed an mRNA vaccine for the H5N1 avian flu drawing...
Arizona researcher publishes study on COVID-19 vaccine and tinnitus
ABC 15 Phoenix· 21 hours agoShaowen Bao, a University of Arizona professor, and Robert Edmonds, a COVID-19 vaccine patient from New Mexico. “It’s very difficult when you have a very sudden event, and ...
Better Buy: Inovio Pharmaceuticals vs. Novavax | The Motley Fool
The Motley Fool· 4 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of ...
Bird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- Mounting cases of bird flu in humans is luring the day trading crowd to snap up stock...
3 Things You Need to Know If You Buy Novavax Today | The Motley Fool
The Motley Fool· 4 days agoNovavax (NVAX 5.30%) stock has both soared and plummeted at times in recent years. Investors...
3 Stocks That Can Help You to Get Richer in 2025 and Beyond
Motley Fool via Yahoo Finance· 2 days agoThe Motley Fool has positions in and recommends Merck, Pfizer, Vanguard S&P 500 ETF, and Veeva...